Unlock instant, AI-driven research and patent intelligence for your innovation.
Cefmenoxime compound and synthetic method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A synthetic method, cefmenoxime technology, applied in the field of drug synthesis, can solve problems such as no literature and patent reports
Inactive Publication Date: 2010-12-29
HAINAN LINGKANG PHARMA CO LTD
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] At present, domestic manufacturers of cefmenoxime preparations mainly rely on imported raw materials for sub-packaging, but there are no literature or patent reports on the production process of cefmenoxime
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] Synthesis of embodiment 12-(2-tritylaminothiazol-4-yl)-2-methoxyiminoacetic acid hydrochloride
[0031] The 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid of 201 grams and the triphenylchloromethane of 280 grams are joined in the DMF of 600ml, reacted at room temperature for 4 hours, then slowly added 1 Literdiisopropyl ether, stirred, precipitated solid, filtered, washed with a small amount of diisopropyl ether, and dried to obtain 460 g of the product, with a yield of 96%.
Embodiment 2
[0032] The synthesis of embodiment 2 cefotaxime hydrochloride
[0033] 326 grams of 2-(2-tritylaminothiazol-4-yl)-2-methoxyiminoacetic acid hydrochloride and 120 ml of N,N-diisopropylethylamine were added to 500 ml of DMF In, reactant is cooled to 10 ℃, add 130 grams (0.68mol) p-toluenesulfonyl chloride, stir reaction at this temperature for 1 hour, then add 185 grams (0.68mol) 7-ACA and 300ml triethylamine, in 5 Stir vigorously at -10°C for 0.5 hours, then add 500ml of 6mol / L hydrochloric acid, raise the temperature to 45°C, stir for 1.5 hours, cool to room temperature, then add 4 liters of acetone and 300ml of water and stir at room temperature to precipitate a solid, filter, Wash with acetone and dry under vacuum at 40° C. to obtain 314 g of product, yield: 94%.
Embodiment 3
[0034] The synthesis of embodiment 3 cefmenoxime
[0035] Dissolve 200 grams of cefotaxime hydrochloride in a mixed solvent of 5000 ml of distilled water and 2500 ml of acetone, add 47.2 grams of 1-methyl-5-mercapto-1H-tetrazolium, stir and heat up to 55 ° C, and then use 3% carbonic acidSodiumaqueous solution adjusts the pH of the reaction system to 6.5-7, reacts at this temperature for 4 hours, adds activated carbon to decolorize, then cools to room temperature, filters, and the filtrate is adjusted to PH=6 with 2mol / L hydrochloric acid, and 500ml of ethyl acetate The ester was extracted twice, and the water phase was adjusted to PH=2.5 with 2 mol / L hydrochloric acid, the solid was precipitated by stirring, filtered, the filter cake was washed with water, and dried to obtain 202 g of the product, with a yield of 93.7%.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a cefmenoxime compound and a synthetic method thereof, in particular to a synthetic method of a cefmenoxime compound, pertaining to the field of drug synthesis technology. Themethod comprises the following steps: (1) aminothiazoly loximate and triphenylchloromethane react in DMF to obtain 2-(2-triphenylmethylaminothiazol-4-yl)-2-methoxy imido acetic acidhydrochloride; (2) the 2-(2- triphenylmethylaminothiazol-4-yl)-2-methoxy imido acetic acidhydrochloride and N, N-diisopropylethylamine are added into the DMF and then paratoluensulfonyl chloride is added and the mixture is stirred for reaction, and then 7-ACA and triethylamine are added for reaction. The pH value is adjusted with hydrochloric acid to obtain hydrochloric cefotaxime acid; and (3) the hydrochloric cefotaxime acid and 1-methyl-5- hydrosulphonyl-1H-tetrazolium react in a mixed solvent and the pH value is adjusted respectively with sodiumcarbonate and hydrochloric acid to obtain cefmenoxime.
Description
technical field [0001] The invention relates to a method for synthesizing cephalosporin compounds, in particular to a method for synthesizing cefmenoxime compounds, and belongs to the technical field of drug synthesis. Background technique [0002] Cefmenoxime, its chemical name is: (6R,7R)-7-[2-(2-amino-4-thiazolyl)(methoxyimino)acetamido]-3-[[(1-methyl- 1H-tetrazol-5-yl)-thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, molecular formula: C 16 h 17 N 9 o 5 S 3 , molecular weight: 511.55, structural formula: [0003] [0004] Cefmenoxime is the third-generation cephalosporin developed by Takeda Corporation of Japan. It was first listed in Japan in 1983. It is a broad-spectrum antibiotic that achieves bactericidal effect by inhibiting the biosynthesis of bacterial cell walls. In vitro tests have shown that cefmenoxime has effects on both gram-positive and gram-negative bacteria, and its strong antibacterial effect on gram-negative bacteria is...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.